The aim of this study is to review the molecular characteristics of the IL-2 family of cytokines, the research progress in tumor immunotherapy and the current status of clinical research, with the goal of providing a comprehensive and broad vision to guide researchers or drug research institutes in future studies and to promote the clinical application of IL-2 family cytokine drugs in tumor immunotherapy. Here, IL2 is linked to neoplasm.